Covidien Further Bulks Up Vascular Biz With Sapheon Buy
This article was originally published in The Gray Sheet
Just one week after inking a deal to buy neurovascular product firm Reverse Medical, Covidien announced the purchase of another vascular device maker, Sapheon, which focuses on venous disease treatments.
You may also be interested in...
VenaSeal was developed by Sapheon Inc., which Covidien acquired in the summer of 2014 shortly after it announced plans to merge with Medtronic.
Medtronic and Covidien have announced two deals each in the past week. The two firms are set to be combined by early next year under a megadeal announced in June.
Covidien will bolster its vascular business through the acquisition of varicose vein treatment marketer VNUS for $440 million